Bill > SB01012

This bill aims to change existing insurance regulations by requiring that contracts between health carriers (insurance companies) and pharmacy benefits managers (PBMs) must use fee-based compensation structures that are completely independent of prescription drug prices, rebates, premiums, or cost-sharing expenses. In practical terms, this means PBMs would be paid a flat fee for their services rather than receiving compensation that varies based on the cost or pricing mechanisms of prescription drugs. The bill seeks to potentially reduce conflicts of interest and create more transparency in how PBMs are compensated for managing prescription drug benefits for health insurance plans. By mandating a fee-based approach that is disconnected from drug pricing, the legislation intends to eliminate potential incentives for PBMs to favor more expensive medications or manipulate drug pricing structures for their own financial gain.

Business and Industry

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB01012&which_year=2025